Cancer Risk

Immunovaccine Announces 2010 Second Quarter Results
HALIFAX, NOVA SCOTIA–(Marketwire – Aug. 27, 2010) – Immunovaccine Inc. (TSX VENTURE:IMV), a clinical theatre vaccine company, currently voiced a operational as well as monetary formula for a second entertain finished Jun 30, 2010 (“Q2 Fiscal 2010″).

Cancer Topics: 2010, Announces, clinical stage, Immunovaccine, Quarter, results, Second, second quarter ended june, tsx venture, vaccine company